Jin Medical International Ltd., often referred to as Jin Medical, is a prominent player in the medical device industry, headquartered in China (CN). Established in 2003, the company has made significant strides in developing innovative healthcare solutions, particularly in the fields of orthopaedics and rehabilitation. With a strong operational presence across Asia and expanding into international markets, Jin Medical is renowned for its advanced surgical instruments and rehabilitation equipment. Their core products, characterised by cutting-edge technology and user-centric design, set them apart in a competitive landscape. Recognised for their commitment to quality and innovation, Jin Medical has achieved notable milestones, including various industry certifications and partnerships that enhance their market position. As a trusted name in medical technology, Jin Medical International Ltd. continues to contribute to improved patient outcomes worldwide.
How does Jin Medical International Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Jin Medical International Ltd.'s score of 15 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Jin Medical International Ltd., headquartered in China (CN), currently does not have specific carbon emissions data available for the most recent year, nor does it report any absolute emissions figures in kg CO2e. As a current subsidiary, Jin Medical International Ltd. does not inherit emissions data from a parent company, and there are no documented reduction targets or climate pledges associated with its operations. The absence of emissions data and reduction initiatives suggests that Jin Medical International Ltd. may still be in the early stages of developing its climate strategy. In the context of the medical device industry, companies are increasingly expected to establish clear climate commitments and reduction targets to align with global sustainability goals. As the company progresses, it may consider adopting industry-standard frameworks such as the Science Based Targets initiative (SBTi) to set measurable and achievable emissions reduction goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Jin Medical International Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
